Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany.
University of Tartu, Institute of Chemistry, Ravila 14a, 50411 Tartu, Estonia.
Biochim Biophys Acta Mol Cell Res. 2021 Mar;1868(3):118930. doi: 10.1016/j.bbamcr.2020.118930. Epub 2020 Dec 19.
BRET and fluorescence anisotropy (FA) are two fluorescence-based techniques used for the characterization of ligand binding to G protein-coupled receptors (GPCRs) and both allow monitoring of ligand binding in real time. In this study, we present the first direct comparison of BRET-based and FA-based binding assays using the human M muscarinic acetylcholine receptor (MR) and two TAMRA (5-carboxytetramethylrhodamine)-labeled fluorescent ligands as a model system. The determined fluorescent ligand affinities from both assays were in good agreement with results obtained from radioligand competition binding experiments. The assays yielded real-time kinetic binding data revealing differences in the mechanism of binding for the investigated fluorescent probes. Furthermore, the investigation of various unlabeled MR ligands yielded pharmacological profiles in accordance with earlier reported data. Taken together, this study showed that BRET- and FA-based binding assays represent valuable alternatives to radioactivity-based methods for screening purposes and for a precise characterization of binding kinetics supporting the exploration of binding mechanisms.
BRET 和荧光各向异性(FA)是两种用于研究配体与 G 蛋白偶联受体(GPCR)结合的荧光基础技术,两者都允许实时监测配体结合。在这项研究中,我们使用人 M 毒蕈碱乙酰胆碱受体(MR)和两种 TAMRA(5-羧基四甲基罗丹明)标记的荧光配体作为模型系统,首次直接比较了基于 BRET 和基于 FA 的结合测定法。两种测定法确定的荧光配体亲和力与放射性配体竞争结合实验获得的结果非常吻合。该测定法提供了实时的动力学结合数据,揭示了所研究的荧光探针结合机制的差异。此外,对各种未标记的 MR 配体的研究得出了与先前报道的数据一致的药理学特征。总之,这项研究表明,BRET 和 FA 基于的结合测定法代表了放射性方法的有价值的替代方法,可用于筛选目的,并可精确表征支持结合机制探索的结合动力学。